Celera abandons gene sequencing The company that shared the glory for unravelling the code of life of human beings has […]

Biotrends Two major reports highlight the globalization of biotechnology and the battle within the U.S. for regional supremacy

Where the Biotech Bets Are John McCamant of The Medical Technology Stock Letter tells where he’s making his in this

Biotech lobbyists’ clout grows in Washington The Biotechnology Industry Organization is still unpacking from its move into a bigger office

Biotech lobbyists’ clout grows in Washington The Biotechnology Industry Organization is still unpacking from its move into a bigger office

Gene Doping Threatens to Transform Sports “If it does take off, sport as we know it will disappear”

FDA Acts To Speed Bioterror Medicines Responding to the threat of anthrax and other forms of chemical and biological terrorism,

A Challenge to Science and Nature A new journal will challenge publishing behemoths such as Science, Nature and Cell by

Life after Venter At Celera Genomics, a new president and questions about the company’s direction.

Biotech heads west for VC The pot of gold to fund biotech research in Memphis may come from Little Rock